Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 105 for:    egcg

The Effect of「GTT-EGCG」on Acne Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01846338
Recruitment Status : Unknown
Verified May 2013 by Chung-Hua Hsu, National Yang Ming University.
Recruitment status was:  Enrolling by invitation
First Posted : May 3, 2013
Last Update Posted : May 3, 2013
Sponsor:
Collaborator:
Taipei City Hospital
Information provided by (Responsible Party):
Chung-Hua Hsu, National Yang Ming University

Brief Summary:
The aim of this study is to investigate the therapeutic effects of green tea extract on acne treatment and related hormone peptides by a double-blinded, randomized and controlled clinical trial.

Condition or disease Intervention/treatment Phase
Acne Lesion Counts Dietary Supplement: green tea extract EGCG Not Applicable

Detailed Description:
change in acne lesions counts, hormone, quality of life

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of「GTT-EGCG」on Acne Women
Study Start Date : October 2012
Estimated Primary Completion Date : June 2013
Estimated Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acne

Arm Intervention/treatment
Experimental: green tea extract EGCG
experimental: green tea extract EGCG, 500mg , tid, 4 weeks
Dietary Supplement: green tea extract EGCG
EGCG, 500mg, tid, 4 weeks

Placebo Comparator: cellulose
Placebo Comparator: cellulose, 500 mg tid, 4 weeks
Dietary Supplement: green tea extract EGCG
EGCG, 500mg, tid, 4 weeks




Primary Outcome Measures :
  1. acne lesion counts [ Time Frame: four weeks ]

Secondary Outcome Measures :
  1. quality of life, SF-12 [ Time Frame: four weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Female patient
  • 20 to 45 years of age
  • moderate or severe acne vulgaris as defined by the Investigator's Global Assessment (IGA; score of 3 or 4 on a scale from 0 to 5)

Exclusion Criteria:

  • Received systemic retinoid or hormone treatment in the previous 3 months.
  • Abnormal liver enzymes or kidney function tests (1.5 times higher than the upper normal limit)
  • abnormal blood chemistry
  • Pregnant or breast feeding women or the intention of becoming pregnant
  • Concurrent systemic illness
  • PCOS
  • Very severe acne(IGA score5)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01846338


Locations
Layout table for location information
Taiwan
Taipei City Hospital
Taipei, Taiwan, 886
Sponsors and Collaborators
National Yang Ming University
Taipei City Hospital